Zobrazeno 1 - 10
of 25
pro vyhledávání: '"C Castaño Amores"'
Publikováno v:
The European Journal of Health Economics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4ffe0ab5cbcb54d07d5a5857c2ee01d
https://doi.org/10.1007/s10198-023-01584-9
https://doi.org/10.1007/s10198-023-01584-9
Publikováno v:
Section 4: Clinical pharmacy services.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4db71a94e86d645c5ca84c3ae26ecee
https://doi.org/10.1136/ejhpharm-2023-eahp.65
https://doi.org/10.1136/ejhpharm-2023-eahp.65
Publikováno v:
Section 4: Clinical pharmacy services.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::346ea658d823ee00de72577777a656e9
https://doi.org/10.1136/ejhpharm-2023-eahp.84
https://doi.org/10.1136/ejhpharm-2023-eahp.84
Autor:
C Castaño-Amores, P Nieto-Gómez, S Portillo-Haro, MT Nieto, X Díaz-Villamarín, CL Dávila-Fajardo
Publikováno v:
Section 4: Clinical pharmacy services.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e8357befaa8e48fb5dab32a114611589
https://doi.org/10.1136/ejhpharm-2022-eahp.111
https://doi.org/10.1136/ejhpharm-2022-eahp.111
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance Inflammatory/autoimmune ophthalmic syndromes (IAOS) are often treated with corticosteroids in severe cases. However, in some cases, corticosteroids can be contraindicated, poorly tolerated or ineffective. This situation is c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51c26ccff8115cf86c938d1691d87679
https://doi.org/10.1136/ejhpharm-2021-eahpconf.150
https://doi.org/10.1136/ejhpharm-2021-eahpconf.150
Autor:
S Portillo Haro, A Rodriguez Delgado, J Cabeza Barrera, P Moreno Rodriguez, P Nieto Gómez, C Castaño-Amores, R Álvarez Sánchez
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance Tofacitinib is an oral JAK inhibitor indicated for the treatment of rheumatoid arthritis, psoriasis arthritis and ulcerative colitis. The efficacy and safety of tofacitinib have been shown in several randomised clinical tria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e1c4fd689c22b3a5456ca1e3ccf3455
https://doi.org/10.1136/ejhpharm-2021-eahpconf.142
https://doi.org/10.1136/ejhpharm-2021-eahpconf.142
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance An outbreak of multiple sclerosis (MS) is defined as symptoms and neurological signs typical of demyelinating disease, with a duration of at least 24 hours It appears in all forms of MS, contributing to short and long term d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c95327fa1cc6ddd817e6331aa0e4f40
https://doi.org/10.1136/ejhpharm-2021-eahpconf.65
https://doi.org/10.1136/ejhpharm-2021-eahpconf.65
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance Neurokinin-1 (NK1) receptor antagonist (RA), netupitant, is usually co-administered with the serotonin (5-HT3) RA, palonosetron, to prevent chemotherapy induced nausea and vomiting. Aim and objectives To analyse potential dr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b9bea45c9a3c5155448208a2db3df195
https://doi.org/10.1136/ejhpharm-2021-eahpconf.49
https://doi.org/10.1136/ejhpharm-2021-eahpconf.49
Autor:
AE Fernández-Gómez, Cristina Lucía Dávila-Fajardo, C Castaño-Amores, A Pozo-Agundo, X Díaz-Villamarín, Alba Antúnez-Rodríguez
Publikováno v:
Section 5: Patient safety and quality assurance.
Background and importance Nutritional support in breast cancer patients has an important role during oncological treatment, which varies according to the stage of the breast tumour. When surgery is performed followed by radiotherapy or chemotherapy,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c61ea62d3891ab0da361b3b8832bfd4
https://doi.org/10.1136/ejhpharm-2021-eahpconf.331
https://doi.org/10.1136/ejhpharm-2021-eahpconf.331
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.